Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.365 CAD
−15.60 M CAD
62.63 M CAD
58.71 M
About EVOME MED TECHNOLOGIES INC
Sector
Industry
CEO
Michael D. Seckler
Website
Headquarters
Shirley
Founded
2013
FIGI
BBG005Y49R58
Evome Medical Technologies, Inc. engages in the provision of financial and consultancy services to the mental health and addiction industry. It operates through the Medical Billing and Financial Services segments. The Medical Billing segment focuses on its customers in United States. The Financial Services segment offers asset based financial services to healthcare providers in the United States. The company was founded by Robert Munro on September 17, 2013 and is headquartered in Shirley, NY.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EVMT is 0.110 CAD — it has decreased by −12.00% in the past 24 hours. Watch EVOME MED TECHNOLOGIES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange EVOME MED TECHNOLOGIES INC stocks are traded under the ticker EVMT.
EVMT stock has risen by 4.76% compared to the previous week, the month change is a −21.43% fall, over the last year EVOME MED TECHNOLOGIES INC has showed a −46.34% decrease.
EVMT reached its all-time high on Apr 2, 2014 with the price of 5.310 CAD, and its all-time low was 0.080 CAD and was reached on Jul 4, 2024. View more price dynamics on EVMT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
EVMT stock is 13.64% volatile and has beta coefficient of 5.48. Track EVOME MED TECHNOLOGIES INC stock price on the chart and check out the list of the most volatile stocks — is EVOME MED TECHNOLOGIES INC there?
Today EVOME MED TECHNOLOGIES INC has the market capitalization of 6.58 M, it has increased by 42.11% over the last week.
Yes, you can track EVOME MED TECHNOLOGIES INC financials in yearly and quarterly reports right on TradingView.
EVOME MED TECHNOLOGIES INC is going to release the next earnings report on Apr 7, 2025. Keep track of upcoming events with our Earnings Calendar.
EVMT net income for the last quarter is −1.15 M CAD, while the quarter before that showed −2.28 M CAD of net income which accounts for 49.68% change. Track more EVOME MED TECHNOLOGIES INC financial stats to get the full picture.
No, EVMT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 205.00 employees. See our rating of the largest employees — is EVOME MED TECHNOLOGIES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EVOME MED TECHNOLOGIES INC EBITDA is −1.60 M CAD, and current EBITDA margin is −1.62%. See more stats in EVOME MED TECHNOLOGIES INC financial statements.
Like other stocks, EVMT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EVOME MED TECHNOLOGIES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EVOME MED TECHNOLOGIES INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EVOME MED TECHNOLOGIES INC stock shows the sell signal. See more of EVOME MED TECHNOLOGIES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.